Israel is a leader in Basalioma treatment, with top facilities like Sourasky Medical Center (Ichilov), Assuta Medical Center, and Hadassah Medical Center accredited by the Joint Commission International. Sourasky Medical Center achieves a 90% success rate in cancer treatments, serving over 400,000 patients annually. Assuta Medical Center, Israel's largest private hospital, focuses on personalized oncology treatments. Hadassah Medical Center treats over 1,000,000 patients annually and is renowned for its oncology services.
Innovative Basalioma treatments in Israel include Mohs micrographic surgery, photodynamic therapy, laser ablation, and targeted drug therapy. The survival rate for Basalioma patients in Israel is notably high, with early-stage treatment success exceeding 95%, thanks to precise diagnostics and personalized treatment plans.